Search Results

6 items found for " Ami Ono"

Posts (1)

Ono Enters into Collaboration Agreement with Domain Therapeutics and Université de Montréal for ...
April 2022 Ono Enters into Collaboration Agreement with Domain Therapeutics and Université de Montréal for GPCR-Targeted Drug Discovery "Apr.19.2022 Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; “Ono”) today announced that it has newly signed a collaboration

Blockade of vasoactive intestinal peptide receptor 2 (VIPR2) signaling suppresses cyclin D1-dependent cell-cycle progression in MCF-7 cells
Authors Satoshi Asano , Ami Ono , Kaede Baba , Teru Uehara , Kotaro Sakamoto , Atsuko Hayata-Takano ,
Vasoactive intestinal peptide receptor 2 signaling promotes breast cancer cell proliferation by enhancing the ERK pathway
excessive expression of VIPR2 may lead to an exacerbation of breast carcinoma. ” Authors Satoshi Asano , Ami Ono , Kotaro Sakamoto , Atsuko Hayata-Takano , Takanobu Nakazawa , Kotaro Tanimoto , Hitoshi Hashimoto
Atypical Structure and Function of Typical Chemokine Receptors
Typical Chemokine Receptors Date & Time Saturday, November 4th / 11:00 AM Abstract Coming Soon About Amy The Ramsey Lab Amy Ramsey on the web University of Toronto Pubmed Google Scholar LinkedIn Twitter Dr.